These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis. Barchetta I; Cimini FA; Dule S; Cavallo MG Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140405 [TBL] [Abstract][Full Text] [Related]
30. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation. Mur C; Arribas M; Benito M; Valverde AM Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620 [TBL] [Abstract][Full Text] [Related]
31. NOD1 activation induces innate immune responses and insulin resistance in human adipocytes. Zhou YJ; Zhou H; Li Y; Song YL Diabetes Metab; 2012 Dec; 38(6):538-43. PubMed ID: 23182460 [TBL] [Abstract][Full Text] [Related]
32. Adiponectin deletion impairs insulin signaling in insulin-sensitive but not insulin-resistant 3T3-L1 adipocytes. Chang E; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY Life Sci; 2015 Jul; 132():93-100. PubMed ID: 25956568 [TBL] [Abstract][Full Text] [Related]
33. Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant. Yu J; Shi L; Wang H; Bilan PJ; Yao Z; Samaan MC; He Q; Klip A; Niu W Eur J Cell Biol; 2011 Dec; 90(12):1000-15. PubMed ID: 21962636 [TBL] [Abstract][Full Text] [Related]
34. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes. Zhao L; Hu P; Zhou Y; Purohit J; Hwang D Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E587-98. PubMed ID: 21693690 [TBL] [Abstract][Full Text] [Related]
35. Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients. Blaslov K; Bulum T; Duvnjak L J Diabetes Complications; 2015 Apr; 29(3):390-4. PubMed ID: 25641023 [TBL] [Abstract][Full Text] [Related]
36. A novel role for neural cell adhesion molecule in modulating insulin signaling and adipocyte differentiation of mouse mesenchymal stem cells. Yang HJ; Xia YY; Wang L; Liu R; Goh KJ; Ju PJ; Feng ZW J Cell Sci; 2011 Aug; 124(Pt 15):2552-60. PubMed ID: 21730021 [TBL] [Abstract][Full Text] [Related]
37. Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin. Barnett AH; Charbonnel B; Donovan M; Fleming D; Chen R Curr Med Res Opin; 2012 Apr; 28(4):513-23. PubMed ID: 22313154 [TBL] [Abstract][Full Text] [Related]
38. Diabetes, hypertension, and chronic kidney disease progression: role of DPP4. Nistala R; Savin V Am J Physiol Renal Physiol; 2017 Apr; 312(4):F661-F670. PubMed ID: 28122713 [TBL] [Abstract][Full Text] [Related]
39. Prevention of obesity-induced renal injury in male mice by DPP4 inhibition. Nistala R; Habibi J; Lastra G; Manrique C; Aroor AR; Hayden MR; Garro M; Meuth A; Johnson M; Whaley-Connell A; Sowers JR Endocrinology; 2014 Jun; 155(6):2266-76. PubMed ID: 24712875 [TBL] [Abstract][Full Text] [Related]
40. Systemic Hypoxia Increases the Expression of DPP4 in Preadipocytes of Healthy Human Participants. Chowdhury HH; Velebit J; Mekjavic IB; Eiken O; Kreft M; Zorec R Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):91-95. PubMed ID: 28950392 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]